Recent research presented at the 2026 ASCO Annual Meeting suggests a correlation between primary insomnia and an increased risk of early-onset cancers. Patients aged 50 and younger diagnosed with insomnia showed higher relative risks for breast, uterine, and ovarian cancers compared to those without the condition. This highlights the potential for sleep health to serve as a clinically modifiable risk factor in cancer prevention.
The Link Between Sleep Disorders and Early-Onset Malignancies
A retrospective cohort study conducted by researchers at Jefferson Health utilized the TriNetX database to analyze health records from January 25, 2021, to January 25, 2026. The study compared over 413,000 adults with primary insomnia against a control group of more than 18 million adults of the same age range. According to the findings presented at the ASCO Annual Meeting, women with insomnia had more than three times the likelihood of developing early-onset breast cancer (RR = 3.15). The study also identified nearly double the risk for uterine cancer (RR = 1.98) and a 50% greater likelihood of ovarian cancer (RR = 1.57).
While the study also tracked outcomes for men, the data regarding prostate and testicular cancers were underpowered to reach statistical significance. Despite the numerical increase in risk, researchers noted that further investigation is required to confirm these associations in male populations.
Biological Mechanisms and Sleep Health
Medical experts are currently exploring why sleep disruption might influence cancer initiation. Vineet Polineni, DO, a resident physician at Jefferson Health, noted that melatonin, which is suppressed by sleep disorders, possesses anti-estrogen effects that may act as a protective element against hormone-driven tumors. Other potential contributors include chronic stress and systemic immune dysregulation resulting from prolonged sleep deprivation.
The rise in early-onset cancers—which have seen a 3% increase over the last three decades—has prompted researchers to look for modifiable lifestyle factors. Danielle C. Thor, DO, MAUB, emphasized that as primary insomnia incidence climbs globally, clinicians should prioritize the diagnosis and management of sleep disorders as a proactive health measure.
Future Research and Clinical Implications
The research team identified several areas for future study, including subgroup analyses based on body mass index (BMI) and age. There is also interest in determining whether these findings extend to other malignancies, such as early-onset colorectal cancer.
Limitations of the study include the potential for underdiagnosis of insomnia in the general population, which may affect the scope of the data. Physicians are encouraged to improve diagnostic accuracy for sleep disorders to better support patient health and refine future clinical research. As the medical community continues to investigate these trends, the focus remains on identifying actionable interventions that can mitigate cancer risk at an earlier age.
Quick Facts: Insomnia and Cancer Risk
- Study Scope: A 5-year retrospective analysis of over 18 million patient records.
- Breast Cancer Risk: Women with primary insomnia showed an RR of 3.15 compared to those without.
- Uterine Cancer Risk: The study found an RR of 1.98 for women with insomnia.
- Ovarian Cancer Risk: Women with insomnia had an RR of 1.57.
- Global Context: An estimated 16% of adults worldwide currently live with insomnia, according to data cited from Sleep Medicine Reviews.